Janos Kappelmayer

Title: Janos Kappelmayer: Innovator in Blood Coagulation Inhibition

Introduction

Janos Kappelmayer is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of medicine, particularly in the area of blood coagulation. His innovative work has led to the development of a unique method that addresses critical challenges in extracorporeal circulation.

Latest Patents

Kappelmayer holds a patent for a method of inhibiting blood coagulation in extracorporeal circulation. This invention provides a method of inhibiting coagulation in a subject by administering a therapeutically effective amount of a monoclonal antibody. This antibody inhibits the ability of tissue factor to bind to factor VII/VIIa. The method effectively prevents complex formation between tissue factor and factor VII/VIIa, thereby inhibiting blood coagulation during extracorporeal procedures such as cardiopulmonary bypass and other shunt procedures. The anti-tissue factor monoclonal antibodies produced by hybridoma cell lines TFS-5G9 or TF9-6B4 may be utilized in these methods. Kappelmayer has 1 patent to his name.

Career Highlights

Throughout his career, Janos Kappelmayer has worked with prestigious institutions, including The Scripps Research Institute and the University of Pennsylvania. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kappelmayer has collaborated with notable individuals such as Thomas S. Edgington and Robert W. Colman. These collaborations have further enriched his research and innovations in the field of blood coagulation.

Conclusion

Janos Kappelmayer's contributions to the field of blood coagulation inhibition are significant and impactful. His innovative methods have the potential to improve patient outcomes in extracorporeal procedures. His work exemplifies the importance of research and innovation in advancing medical science.